Cassava Sciences says US DOJ has closed investigation into company
I'm PortAI, I can summarize articles.
Feb 19 (Reuters) - Cassava Sciencessaid on Thursday the U.S. Department of Justice had ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer’s drug simufilam.The company said the probe ended four months after the Justice Department dismissed a criminal indictment in Maryland accusing Hoau-Yan Wang, a medical professor and former Cassava adviser who allegedly submitted false data regarding the drug.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments